Cite

HARVARD Citation

    Bolaños-Mateo, E. et al. (n.d.). Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record